News|Articles|September 18, 2026

The future of GLP-1 and glucose management (Sept 2026)

Author(s)Rousselot

Rethink what you know about collagen peptides. They’re more than skincare. More than added nutrition. Clinical studies have shown promise for their role in reducing glucose spikes and supporting natural GLP-1 response — but it depends on the specific collagen peptides. Read the white paper to explore the science and market opportunities for supplements and functional foods and beverages.


Related to this article

SupplySide Global Vitaquest
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Michael Anthonavage, VP of innovation at Vitaquest International, about the company’s 2027 consumer trends forecast and how it’s shaping supplement formulation.
Laurentia Bliss
Live from SupplySide Global 2026, Laurentia Bliss talks about new athlete-focused research on Magtein, ThreoTech’s brain-targeted magnesium ingredient, and upcoming innovations like effervescent tablets and gummies.
Klaus Neumann
Live from SupplySide Global 2026, Klaus Neumann talks about Concordix's chewable supplement line spanning beauty and gut-immune health, including BeautyBioti, a Skin & Hair Vitality Complex, and FortiBiotic.